EADV Congress 2025

Congress coverage by Medthority

Last updated: 2nd Oct 2025

Published: 2nd Oct 2025

From new approaches to alopecia areata (AA) assessment to emerging agents for hidradenitis suppurativa (HS), catch up on the insights you might have missed at this year’s European Academy of Dermatology and Venereology (EADV) Congress.

Microscopic image of Hidradenitis suppurativa in axillary mass tissues, blue overlay

EADV 2025: HS highlights

Emerging agents to address unmet needs

EADV 2025: AA highlights

Sonographic biomarkers and real-world evidence

Developed by EPG Health for Medthority, independently of any sponsor.

Navigating CSU: Timing and novel agents

Updates from EADV Congress 2025 on managing chronic spontaneous urticaria (CSU), including early vs late biologic use and comparative insights on advanced therapies.

Developed independently by EPG Health with an educational grant from Novartis.

READ NOW

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information

Name

Email address

Specialty

By providing your email address, you are opting in to receive our monthly newsletter.

Opt-in: By selecting this box, I consent to receiving marketing communications and information about Medthority's resources by email.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.